| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1801 | 2023 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 542 | 2021 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 449 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 430 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 426 | 2024 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 388 | 2021 |
| Human genetic and immunological determinants of critical COVID-19 pneumonia Q Zhang, P Bastard, A Cobat, JL Casanova Nature 603 (7902), 587-598, 2022 | 286 | 2022 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 280 | 2024 |
| Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized … GA Ospina-Tascón, LE Calderón-Tapia, AF García, V Zarama, ... Jama 326 (21), 2161-2171, 2021 | 279 | 2021 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 274 | 2024 |
| Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients MI Restrepo, BL Babu, LF Reyes, JD Chalmers, NJ Soni, O Sibila, ... European Respiratory Journal 52 (2), 2018 | 223 | 2018 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 209 | 2021 |
| Prevalence and etiology of community-acquired pneumonia in immunocompromised patients MF Di Pasquale, G Sotgiu, A Gramegna, D Radovanovic, S Terraneo, ... Clinical Infectious Diseases 68 (9), 1482-1493, 2019 | 189 | 2019 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 182 | 2024 |
| Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study G Moreno, A Rodríguez, LF Reyes, J Gomez, J Sole-Violan, E Díaz, ... Intensive care medicine 44, 1470-1482, 2018 | 169 | 2018 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 164 | 2022 |
| Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, ... The Lancet Infectious Diseases 16 (12), 1364-1376, 2016 | 163* | 2016 |
| Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development D Munblit, TR Nicholson, DM Needham, N Seylanova, C Parr, J Chen, ... BMC medicine 20 (1), 50, 2022 | 138 | 2022 |
| Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study A Tabah, N Buetti, Q Staiquly, S Ruckly, M Akova, AT Aslan, M Leone, ... Intensive care medicine 49 (2), 178-190, 2023 | 135 | 2023 |
| Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling LF Reyes, MI Restrepo, CA Hinojosa, NJ Soni, A Anzueto, BL Babu, ... American Journal of Respiratory and Critical Care Medicine 196 (5), 609-620, 2017 | 133 | 2017 |
Alejandro RodríguezCritical Care Department - Hospital Universitario de Tarragona Joan XXIIIAdresse e-mail validée de urv.cat